Indications, Dosages and Administration of FDA-Approved Drugs Form
Background for this Policy
For purposes of this policy, a U.S. Food and Drug Administration (FDA)-approved prescription drug is defined as an FDA-approved drug, biological, or compounded prescription which, by State and Federal Law, may be dispensed only by prescription or administered by a person who is acting within his or her capacity as a paid health professional.
For purposes of this policy, compendia accepted indications include AHFS Drug Information or LexiDrugs (Supportive), DrugDex (must have
bothStrength of Recommendation Class I or IIa
plusStrength of Evidence Category A or B), Clinical Pharmacology (must have
bothQuality of Evidence High or Moderate
plusStrength of Recommendation Strong), and NCCN Drugs & Biologics Compendium (Categories of Consensus I and IIa).
In the absence of a published Aetna Clinical Policy Bulletin (CPB) to the contrary, U.S. Food and Drug Administration (FDA)-approved prescription drugs are considered medically necessary for an indication if:
In the absence of a published Aetna CPB to the contrary, the medically necessary dosage of an FDA-approved presciption drug for an indication is equal to any of the following:
: Nothing in this policy should be interpreted as limiting Aetna's ability to require pre-certification of coverage of any given product. Coverage may also be subject to pharmacy benefit management programs and formulary restrictions. Please check benefit plan descriptions for details.
Walk through this policy with us
Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.